Japan-based companies Fujitsu and TOPPAN Holdings Inc. have concluded a business alliance agreement to jointly promote t...
Fujitsu Limited and the High Performance Computing (HPC)- and AI-driven Drug Development Platform Division of the RIKEN ...
GlaxoSmithKline K.K. and National University Corporation Kyushu University have signed a strategic partnership agreement...
Lightstone Ventures, ClavystBio, Leaps by Bayer, Polaris Partners, and the Polaris Innovation Fund, along with global li...
The life sciences industry is entering a digital renaissance. Organizations are increasingly exploring and investing in ...
PeptiDream Inc., a Japan-based biopharmaceutical company, has announced a new multi-target collaboration and license agr...
South Korea-based startup Standigm, a company using artificial intelligence (AI) technology for drug discovery and devel...
Japanese firms Chugai Pharmaceutical Co., and Omron Corporation are working together on the automation of research proce...
Rapid developments are taking place across the fields of artificial intelligence (AI) and biotechnology, and application...
The University of Sydney, Australia has signed a Memorandum of Understanding (MoU) with Pharos Therapeutics, the Austral...
South Korean firms HanAll Biopharma and Daewoong Pharmaceutical have entered into a co-development agreement with N...
Prime Minister Fumio Kishida has recently announced the Government of Japan's pledge to contribute&n...
South Korea-based Avixgen is currently having a strong pipeline in ophthalmic diseases such as age related macular degen...
Japanese firm Fujitsu has announced the commercial debut of its "Biodrug Design Accelerator," a platform to manage resea...
The US Food and Drug Administration (FDA) has announced the supplemental approval of Rexulti (brexpiprazole) o...
Japanese pharmaceutical firm Eisai Co. has entered into a joint development agreement with China-based startup Bliss Bio...
South Korea-based Daewoong Pharmaceutical has signed a Global License Agreement for its autoimmune disease drug can...
South Korean firm Daewoong Pharmaceutical has entered a research collaboration with UK-based Sygnature Discovery to expa...
